Abstract The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is …

Haploidentical donors are now increasingly considered for transplantation in the absence of
HLA-matched donors or when an urgent transplant is needed. Donor-specific anti-HLA …

Background The introduction of solid-phase immunoassay (SPI) technology for the detection
and characterization of human leukocyte antigen (HLA) antibodies in transplantation while …

HLA antigens are polymorphic proteins expressed on donor kidney allograft endothelium
and are critical targets for recipient immune recognition. HLA antibodies are risk factors for …

Solid phase multiplex-bead arrays for the detection and characterization of HLA antibodies
provide increased sensitivity and specificity compared to conventional lymphocyte-based …

This review outlines the development of human leukocyte antigen (HLA) antibody detection
assays and their use in organ transplantation in both antibody screening and crossmatching …

Sensitization, defined as the presence of circulating antibodies, presents challenges for
heart transplant recipients and physicians. When present, sensitization can limit a …

The detection and semiquantitative measurement of circulating human leucocyte antigen
(HLA)‐specific antibodies is essential for the management of patients before and after …

The detection of antibodies against the human leukocyte antigen (HLA) complex has
become indispensable in every clinical practice. The development of solid-phase assays …

The development of sensitive methods for alloantibody detection has been a significant
advance in clinical transplantation. However, the complexity of the data from solid phase …